Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about compliance certificate

29 Apr 2020 Evaluate

Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Aurobindo Pharma has informed that it has enclosed the compliance certificate for the half year ended 31.03.2020.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1761.95
Dr. Reddys Labs. 1344.60
Cipla 1358.00
Lupin 1994.65
Zydus Lifesciences 1176.50
View more..